Mabylon Company
Mabylon is a biotechnology company that leverages a technology platform to discover and engineer antibody therapeutics. It focuses on therapies for allergies, inflammation, and neurology. The company's goal is to rapidly create antibody libraries from which therapeutically relevant products are selected.
Headquarters:
Schlieren, Zurich, Switzerland, Europe
Founded Date:
2015-01-01
Industry:
Drug Discovery & Development
Employee Number:
11-50
Super Industry:
Biopharma & Life Science Tools
Phone Number:
41 44 731 94 09
Investors:
Innosuisse, Target ALS Foundation, The ALS Association
Ipo Status:
private
City:
Schlieren
Region:
Zurich
Country:
Switzerland